THE ROLE OF RADIOLOGICAL METHODS IN THE DIFFERENTIAL DIAGNOSIS TUMORS OF SOFT TISSUE

Authors

  • Nishanova Y.X1., Khodjamova G.A1., Valiyev Y.Y1. Мadumarova Z.Sh2. Xafizova R.R2. Xusanbayeva D.D1., Juravlev I.I3. Sobirova Z.A1. 1. Tashkent medical academy 2. Andijan state medical academy 3. Republican specialized scientific and practical medical center oncology and radiology

Keywords:

Soft tissue sarcoma, computed tomography, magnetic resonance imaging, positron emission tomography.

Abstract

Soft tissue sarcomas are rare and a heterogeneous group of neoplasms. Over the years imaging has played a crucial role in the initial staging, monitoring response to chemotherapy, and surveillance for recurrence. In the era of rapidly evolving individualized treatment due to evolving chemotherapies, increasing demand has been placed on the role of imaging in the management of this heterogeneous group. The rapidly evolving technologies in imaging are trying to keep up with the challenge, with development of newer strategies and hybrid imaging. However, many of these newer technologies are either not available or too costly, even in advanced countries, and hence their exact role remains uncertain. Due to this, and the vast diversity of sarcomas, the imaging appearance and management strategies vary and there is no universally accepted algorithm for the role of individual imaging technologies. The basic imaging techniques; however, remain the same, with these newer techniques and strategies vying for their roles in management. We review current imaging techniques and their role in the management of soft tissue sarcomas.

References

Clark MA, Fisher C, Judson I, et al. Soft-tissue sarcomas in adults. N Engl J Med 2005;353:701-11.

Teniola O, Wang KY, Wang WL, et al. Imaging of liposarcomas for clinicians: Characteristic features and differential considerations. J Surg Oncol 2018;117:1195-203.

Simon MA, Finn HA. Diagnostic strategy for bone and soft-tissue tumors. J Bone Joint Surg Am 1993;75:622-31.

Wu JS, Hochman MG. Soft-tissue tumors and tumorlike lesions: a systematic imaging approach. Radiology 2009;253:297-316.

Gupta P, Potti TA, Wuertzer SD, et al. Spectrum of Fat-containing Soft-Tissue Masses at MR Imaging: The Common, the Uncommon, the Characteristic, and the Sometimes Confusing. Radiographics 2016;36:753-66.

Wang XL, Malghem J, Parizel PM, et al. Pictorial essay. Myositis ossificans circumscripta. JBR-BTR 2003;86:278-85.

Martinez S, Vogler JB 3rd, Harrelson JM, et al. Imaging of tumoral calcinosis: new observations. Radiology 1990;174:215-22.

Wilkerson BW, Crim JR, Hung M, et al. Characterization of synovial sarcoma calcification. AJR Am J Roentgenol 2012;199:W730-4.

Gartner L, Pearce CJ, Saifuddin A. The role of the plain radiograph in the characterisation of soft tissue tumours. Skeletal Radiol 2009;38:549-58.

Shapeero LG, Vanel D, Couanet D, et al. Extraskeletal mesenchymal chondrosarcoma. Radiology 1993;186:819-26.

Kransdorf MJ, Meis JM. From the archives of the AFIP. Extraskeletal osseous and cartilaginous tumors of the extremities. Radiographics 1993;13:853-84.

Subhawong TK, Fishman EK, Swart JE, et al. Soft-tissue masses and masslike conditions: what does CT add to diagnosis and management? AJR Am J Roentgenol 2010;194:1559-67.

Panicek DM, Gatsonis C, Rosenthal DI, et al. CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: Report of the Radiology Diagnostic Oncology Group. Radiology 1997;202:237-46.

Murphey MD, Carroll JF, Flemming DJ, et al. From the archives of the AFIP: benign musculoskeletal lipomatous lesions. Radiographics 2004;24:1433-66.

Knapp EL, Kransdorf MJ, Letson GD. Diagnostic imaging update: soft tissue sarcomas. Cancer Control 2005;12:22-6.

Expert Panel on Musculoskeletal I, Kransdorf MJ, Murphey MD, et al. ACR Appropriateness Criteria((R)) Soft-Tissue Masses. J Am Coll Radiol 2018;15:S189-97.

Li Y, Zheng Y, Lin J, et al. Evaluation of the relationship between extremity soft tissue sarcomas and adjacent major vessels using contrast-enhanced multidetector CT and three-dimensional volume-rendered CT angiography: a preliminary study. Acta Radiol 2013;54:966-72.

Aycock RD, Westafer LM, Boxen JL, et al. Acute Kidney Injury After Computed Tomography: A Meta-analysis. Ann Emerg Med 2018;71:44-53.e4.

Roberts CC, Kransdorf MJ, Beaman FD, et al. ACR Appropriateness Criteria Follow-Up of Malignant or Aggressive Musculoskeletal Tumors. J Am Coll Radiol 2016;13:389-400.

Reuther G, Mutschler W. Detection of local recurrent disease in musculoskeletal tumors: magnetic resonance imaging versus computed tomography. Skeletal Radiol 1990;19:85-90.

Group EESNW. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014;25 Suppl 3:iii102-12.

Sardenberg RA, Figueiredo LP, Haddad FJ, et al. Pulmonary metastasectomy from soft tissue sarcomas. Clinics (Sao Paulo) 2010;65:871-6.

Garcia-Figueiras R, Goh VJ, Padhani AR, et al. CT perfusion in oncologic imaging: a useful tool? AJR Am J Roentgenol 2013;200:8-19.

Widmann G, Riedl A, Schoepf D, et al. State-of-theart HR-US imaging findings of the most frequent musculoskeletal soft-tissue tumors. Skeletal Radiol 2009;38:637-49.

Amini B, Jessop AC, Ganeshan DM, et al. Contemporary imaging of soft tissue sarcomas. J Surg Oncol 2015;111:496-503.

Belli P, Costantini M, Mirk P, et al. Role of color Doppler sonography in the assessment of musculoskeletal soft tissue masses. J Ultrasound Med 2000;19:823-30.

Bermejo A, De Bustamante TD, Martinez A, et al. MR imaging in the evaluation of cystic-appearing soft-tissue masses of the extremities. Radiographics 2013;33:833-55.

Carra BJ, Bui-Mansfield LT, O'Brien SD, et al. Sonography of musculoskeletal soft-tissue masses: techniques, pearls, and pitfalls. AJR Am J Roentgenol 2014;202:1281-90.

Hung EH, Griffith JF, Ng AW, et al. Ultrasound of musculoskeletal soft-tissue tumors superficial to the investing fascia. AJR Am J Roentgenol 2014;202:W532-40.

Bui-Mansfield LT, Chen DC, O'Brien SD. Accuracy of ultrasound of musculoskeletal soft-tissue tumors. AJR Am J Roentgenol 2015;204:W218.

Gay F, Pierucci F, Zimmerman V, et al. Contrastenhanced ultrasonography of peripheral soft-tissue tumors: Feasibility study and preliminary results. Diagn Interv Imaging 2012;93:37-46.

Stramare R, Gazzola M, Coran A, et al. Contrast-enhanced ultrasound findings in soft-tissue lesions: preliminary results. J Ultrasound 2013;16:21-7.

Loizides A, Peer S, Plaikner M, et al. Perfusion pattern of musculoskeletal masses using contrast-enhanced ultrasound: a helpful tool for characterisation? Eur Radiol 2012;22:1803-11. 34. Gruber L, Loizides A, Luger AK, et al. Soft-Tissue Tumor Contrast Enhancement Patterns: Diagnostic Value and Comparison Between Ultrasound and MRI. AJR Am J Roentgenol 2017;208:393-401.

Gulati M, Hu JS, Desai B, et al. Contrast-Enhanced Sonography for Monitoring Neoadjuvant Chemotherapy in Soft Tissue Sarcomas. J Ultrasound Med 2015;34:1489-99.

Hahn S, Lee YH, Lee SH, et al. Value of the Strain Ratio on Ultrasonic Elastography for Differentiation of Benign and Malignant Soft Tissue Tumors. J Ultrasound Med 2017;36:121-7.

Li S, Liu L, Lv G. Diagnostic value of strain elastography for differentiating benign and malignant soft tissue masses. Oncol Lett 2017;14:2041-4.

Pass B, Jafari M, Rowbotham E, et al. Do quantitative and qualitative shear wave elastography have a role in Patel and Matcuk. Imaging of soft tissue sarcomas © Chinese Clinical Oncology. All rights reserved. cco.amegroups.com Chin Clin Oncol 2018;7(4):35 evaluating musculoskeletal soft tissue masses? Eur Radiol 2017;27:723-31.

Delfaut EM, Beltran J, Johnson G, et al. Fat suppression in MR imaging: techniques and pitfalls. Radiographics 1999;19:373-82.

Lang P, Honda G, Roberts T, et al. Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic postcontrast MR images with spatial mapping of instantaneous enhancement rates. Radiology 1995;197:831-9.

Panicek DM, Schwartz LH. Soft tissue edema around musculoskeletal sarcomas at magnetic resonance imaging. Sarcoma 1997;1:189-91.

Hardy PA, Kucharczyk W, Henkelman RM. Cause of signal loss in MR images of old hemorrhagic lesions. Radiology 1990;174:549-55.

Miwa S, Otsuka T. Practical use of imaging technique for management of bone and soft tissue tumors. J Orthop Sci 2017;22:391-400.

Verstraete KL, Lang P. Bone and soft tissue tumors: the role of contrast agents for MR imaging. Eur J Radiol 2000;34:229-46.

Verstraete KL, Van der Woude HJ, Hogendoorn PC, et al. Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging 1996;6:311-21.

Shapeero LG, Vanel D, Verstraete KL, et al. Fast magnetic resonance imaging with contrast for soft tissue sarcoma viability. Clin Orthop Relat Res 2002:212-27. 47. van der Woude HJ, Verstraete KL, Hogendoorn PC, et al. Musculoskeletal tumors: does fast dynamic contrastenhanced subtraction MR imaging contribute to the characterization? Radiology 1998;208:821-8.

Tuncbilek N, Karakas HM, Okten OO. Dynamic contrast enhanced MRI in the differential diagnosis of soft tissue tumors. Eur J Radiol 2005;53:500-5.

van Rijswijk CS, Geirnaerdt MJ, Hogendoorn PC, et al. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy. Radiology 2004;233:493-502.

Verstraete KL, De Deene Y, Roels H, et al. Benign and malignant musculoskeletal lesions: dynamic contrastenhanced MR imaging--parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 1994;192:835-43.

Costa FM, Ferreira EC, Vianna EM. Diffusion-weighted magnetic resonance imaging for the evaluation of musculoskeletal tumors. Magn Reson Imaging Clin N Am 2011;19:159-80.

Padhani AR, Koh DM. Diffusion MR imaging for monitoring of treatment response. Magn Reson Imaging Clin N Am 2011;19:181-209.

van Rijswijk CS, Kunz P, Hogendoorn PC, et al. Diffusion-weighted MRI in the characterization of softtissue tumors. J Magn Reson Imaging 2002;15:302-7.

Nagata S, Nishimura H, Uchida M, et al. Usefulness of diffusion-weighted MRI in differentiating benign from malignant musculoskeletal tumors. Nihon Igaku Hoshasen Gakkai Zasshi 2005;65:30-6.

Einarsdottir H, Karlsson M, Wejde J, et al. Diffusionweighted MRI of soft tissue tumours. Eur Radiol 2004;14:959-63.

Del Grande F, Subhawong T, Weber K, et al. Detection of soft-tissue sarcoma recurrence: added value of functional MR imaging techniques at 3.0 T. Radiology 2014;271:499-511.

Dudeck O, Zeile M, Pink D, et al. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas. J Magn Reson Imaging 2008;27:1109-13.

Subhawong TK, Wang X, Durand DJ, et al. Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions. AJR Am J Roentgenol 2012;198:162-72.

Fayad LM, Barker PB, Bluemke DA. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy. Semin Musculoskelet Radiol 2007;11:240-5.

Doganay S, Altinok T, Alkan A, et al. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors. Eur J Radiol 2011;79:e33-7.

Fayad LM, Wang X, Blakeley JO, et al. Characterization of peripheral nerve sheath tumors with 3T proton MR spectroscopy. AJNR Am J Neuroradiol 2014;35:1035-41.

Drape JL. Advances in magnetic resonance imaging of musculoskeletal tumours. Orthop Traumatol Surg Res 2013;99:S115-23.

Bojadzieva J, Amini B, Day SF, et al. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic. Fam Cancer 2018;17:287-94.

Gorelik N, Reddy SMV, Turcotte RE, et al. Early detection of metastases using whole-body MRI for initial staging and routine follow-up of myxoid liposarcoma. Skeletal Radiol 2018;47:369-79.

Jager PL, Hoekstra HJ, Leeuw J, et al. Routine bone Chinese Clinical Oncology, Vol 7, No 4 August 2018 © Chinese Clinical Oncology. All rights reserved. cco.amegroups.com Chin Clin Oncol 2018;7(4):35 Page 21 of 22 scintigraphy in primary staging of soft tissue sarcoma; Is it worthwhile? Cancer 2000;89:1726-31. 66. Ioannidis JP, Lau J. 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med 2003;44:717-24.

Folpe AL, Lyles RH, Sprouse JT, et al. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 2000;6:1279-87.

Eary JF, O'Sullivan F, Powitan Y, et al. Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. Eur J Nucl Med Mol Imaging 2002;29:1149-54.

Eary JF, O'Sullivan F, O'Sullivan J, et al. Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome. J Nucl Med 2008;49:1973-9.

Rakheja R, Makis W, Tulbah R, et al. Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas. AJR Am J Roentgenol 2013;201:170-7

Downloads

Published

2023-04-06

How to Cite

Nishanova Y.X1., Khodjamova G.A1., Valiyev Y.Y1. Мadumarova Z.Sh2. Xafizova R.R2. Xusanbayeva D.D1., Juravlev I.I3. Sobirova Z.A1. (2023). THE ROLE OF RADIOLOGICAL METHODS IN THE DIFFERENTIAL DIAGNOSIS TUMORS OF SOFT TISSUE. IQRO , 2(2), 305–324. Retrieved from https://wordlyknowledge.uz/index.php/iqro/article/view/603